Director ELLITHORPE G THOMPSON buys 1,948 shares of UBFO at $9.79; stock now -15.7% from 52-week high.
Director ELLITHORPE G THOMPSON purchased 1,948 shares at $9.79 on 2025-05-29, increasing holdings to 88,553 shares (+2.2% vs pre-transaction). The stock has declined to $8.69, down 15.7% from its 52-week high of $10.31 and off 3.4% in the past 30 days. His same-ticker history at UBFO shows 5 prior buys with mixed outcomes: 3 of 5 were well-timed at the 90-day mark, but 2 experienced 90-day declines (including a -4.2% return on the 2024-02-20 purchase). The current purchase occurred after recent price weakness, but absent additional disclosure, the timing signal remains ambiguous given the pattern of mixed execution at this ticker. The company trades at a 11.43 P/E with flat annual revenue growth (+0.0%), which warrants observation of post-transaction performance relative to the insider's historical same-ticker results.
Director Ellithorpe G Thompson buys 1,471 shares of UBFO at $9.79; holdings now 86,364 shares.
Thompson purchased 1,471 shares at $9.79, increasing his holdings by 1.7% to 86,364 shares post-transaction. The stock is currently trading at $9.83, unchanged from its 52-week high of $9.83, and has risen 10.2% over the past 30 days and 18.4% over 90 days. Notably, Thompson has demonstrated strong timing in his prior trades at this ticker: 3 of 4 prior buys at UBFO posted positive 90-day returns, with most recent purchases at this ticker occurring in early 2024 and mid-2023. His cross-ticker track record shows 4 prior buys with an average 90-day return of 7.8% and a 75% win rate. The company trades at a P/E of 9.64 with a market cap of $170.3M, though it has experienced -3.6% annual revenue decline. This purchase occurs amid a period of positive price momentum and aligns with the insider's historical pattern of well-timed entry points, particularly at this security.
